The PMPRB has released a list of potential sources for prices in the PMPRB 11 basket of reference countries. A non-exhaustive list of examples of potential foreign sources can be found here.

Starting July 1, 2021, the Patented Medicines Regulations will require patentees to report the publicly available ex-factory prices at which their products are sold in each of the eleven comparator countries.   

If you are interested in assessing the implications for products prior to July 1, 2021, please send inquiries to Jennifer Mathews, Manager, Pricing Data at PDCI,  to obtain a quote for a PMPRB11 analysis